What question did this study set out to answer?

To measure the prevalence and regional distribution of antibodies against HTLV-I and HTLV-III across diverse regional populations in Kenya.

June 15, 1985International Journal of Cancer

Regional variation in prevalence of antibody against human T‐lymphotropic virus types I and III in Kenya, East Africa

View Full Paper

Ask AI

Bookmark

To measure the prevalence and regional distribution of antibodies against HTLV-I and HTLV-III across diverse regional populations in Kenya.
Tested serum samples across six distinct geographic regions of Kenya using enzyme-linked immunosorbent assay (ELISA) screening.
Assessed assay specificity and cross-reactivity using Western blot confirmatory testing on a subset of samples with high (ratio > 5.0) and low ELISA reactivity.
Evaluated seroprevalence patterns among patient cohorts diagnosed with endemic parasitic and infectious diseases.
Overall HTLV-III ELISA seroprevalence was 21%, ranging from 8% among the Masai to 50% among the Turkana, with prevalence increasing with age but showing no sex predilection.
Western blot confirmation identified virus-specific band patterns in 66% of HTLV-III and 73% of HTLV-I reactive ELISA samples, with no cross-reactivity observed between the viruses.
High proportions of antibodies to both HTLV-I and HTLV-III were detected in individuals presenting with idiopathic splenomegaly and schistosomiasis.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Cross-sectional survey reveals marked geographic differences in HTLV-I and HTLV-III seroprevalence across regional populations, suggesting distinct environmental or demographic transmission factors.

Cite This Study

Biggar et al. (1985) studied this question.

synapsesocial.com/papers/6a92829aeb36ee422618222f https://doi.org/10.1002/ijc.2910350611

View Full Paper

Ask AI

Bookmark

Implication

Cross-sectional survey reveals marked geographic differences in HTLV-I and HTLV-III seroprevalence across regional populations, suggesting distinct environmental or demographic transmission factors.

Regional variation in prevalence of antibody against human T‐lymphotropic virus types I and III in Kenya, East Africa

Key Points

Discussion

Implication

Cite This Study

Regional variation in prevalence of antibody against human T‐lymphotropic virus types I and III in Kenya, East Africa

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider